マーケットレポート詳細
医療診断用AI（人工知能）の世界市場：2027年に至る用途別、エンドユーザー別予測
Artificial Intelligence (AI) in Medical Diagnostics Market by Component (Software, Service), Application (In Vivo, Radiology, Neurology, CT, MRI, X - ray, IVD), End User (Hospital, Diagnostic Imaging Center, Diagnostic Laboratory) - Global Forecast to 2027
- 出版元：MarketsandMarkets
出版元について - 発行年：2022年10月
- 定価 ：Single User License(1名様ライセンス)US$4,950(米国ドル)/ Multi User License(5名様)$6,650 / Corporate User License $8,150
- ご予算に応じた各種ご提案も承ります。詳細はお問い合わせください。
- ご請求は円換算（お見積り日TTSレート）となります。
- 納品形態：PDF by Email
- 当調査レポートは英文173ページになります。
- 商品コード：MAM3076
お問い合わせ、お見積りのリクエストは下のボタンをクリックしてご入力ください。
【レポート紹介】
医療診断用AI（人工知能）の世界市場規模は2022年で10億ドル、2027年で55億ドル、市場の平均年成長率は39.9%に達する予測です。レポートは医療診断用AI（人工知能）の世界市場について2027年までの市場予測データ(金額US$)を掲載しています。
同市場をさまざまな区分で細分化し、そのセグメント市場ごとの市場予測（コンポーネント別市場、用途別市場等）を中心に構成されています。また競合状況、主要企業情報（10社）、バリューチェーン分析、ファイブフォース分析、競合状況などの分析も加味し、医療診断用AI（人工知能）市場の動向および今後成長性を詳細にレポートしています。
【レポート構成概要】
◆医療診断用AI（人工知能）の世界市場予測2020-2027年
・市場規模(US$)
◆コンポーネント別、市場-2027年
・ソフトウェア
・サービス
※(市場規模US$)
◆用途別、市場-2027年
In vivo診断
（専門分野別）
・放射線学
・心臓病学
・神経学
・産科/婦人科
・眼科
・その他専門
（モダリティ別）
・コンピュータ断層撮影（CT）
・Ｘ線
・磁気共鳴画像（MRI）
・超音波
・その他モダリティ
In vitro診断
※(市場規模US$)
◆エンドユーザー別、市場-2027年
・病院
・画像診断センター
・診断ラボラトリー
・その他エンドユーザー
※（市場規模US$）
◆主要国地域別市場-2027年
北米
・米国、カナダ
欧州
・ドイツ、英国、フランス、イタリア
・その他欧州
アジア太平洋
・日本、中国、インド
・その他アジア太平洋
その他地域
※国地域別に全セグメントの細分化データ掲載、詳細は目次参照
◆市場分析
・市場ダイナミクス(ドライバー、障壁、機会、課題)
・バリューチェーン分析
・ケーススタディ
・技術分析
・規制
・ファイブフォース分析
・業界トレンド
・価格分析
・競合状況
◆医療診断用AI（人工知能）の主要企業プロフィール動向
・MICROSOFT CORPORATION
・NVIDIA
・IBM
・INTEL
・GOOGLE （SUBSIDIARY OF ALPHABET, INC.）
・SIEMENS HEALTHINEERS
・GE HEALTHCARE
・DIGITAL DIAGNOSTICS （FORMERLY KNOWN AS IDX）
・XILINX
・INFORMAI
（その他企業）
・HEARTFLOW
・ENLITIC
・DAY ZERO DIAGNOSTICS, INC
・AIDENCE
・BUTTERFLY NETWORK, INC.
・PROGNOS HEALTH
・NANOX AI
・VIZ.AI, INC
・QUIBIM
・QURE.AI
・THERAPIXEL
・AIDOC
・KONINKLIJKE PHILIPS N.V.
・LUNIT. INC
・ECHONOUS INC.
（全173頁）
【レポート詳細目次、データ項目一覧は当ページ下を参照ください】
Table of Contents (英文詳細目次）
1.... INTRODUCTION
1.1 STUDY OBJECTIVES
1.2 MARKET DEFINITION
1.3 INCLUSIONS & EXCLUSIONS
1.3.1 INCLUSIONS AND EXCLUSIONS
1.4 MARKETS COVERED
・ FIGURE 1......... AI IN MEDICAL DIAGNOSTICS MARKET SEGMENTATION
1.4.1 YEARS CONSIDERED.. 26
1.5 CURRENCY CONSIDERED
1.6 LIMITATIONS
1.6.1 SCOPE-RELATED LIMITATIONS
1.6.2 METHODOLOGY-RELATED LIMITATIONS
1.7 STAKEHOLDERS
1.8 SUMMARY OF CHANGES
2.... RESEARCH METHODOLOGY
2.1 RESEARCH DATA
・ FIGURE 2...................................................... RESEARCH DESIGN.. 29
2.1.1 SECONDARY DATA
2.1.1.1 KEY DATA FROM SECONDARY SOURCES
2.1.2 PRIMARY DATA
・ FIGURE 3..................................................... PRIMARY SOURCES.. 32
2.1.2.1 KEY INDUSTRY INSIGHTS
・ FIGURE 4.. BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
2.2 MARKET SIZE ESTIMATION
・ FIGURE 5............. RESEARCH METHODOLOGY: HYPOTHESIS BUILDING
・ FIGURE 6............................................. MARKET SIZE ESTIMATION
・ TABLE 1......................................................... FACTOR ANALYSIS.. 35
・ FIGURE 7... AI IN MEDICAL DIAGNOSTICS MARKET: CAGR PROJECTIONS FROM ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES (2022–2027)
・ FIGURE 8..................... CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS
・ FIGURE 9................................................. TOP-DOWN APPROACH.. 37
2.3 MARKET DATA ESTIMATION AND TRIANGULATION
・ FIGURE 10............................ DATA TRIANGULATION METHODOLOGY
2.4 STUDY ASSUMPTIONS
2.5 RISK ASSESSMENT
・ TABLE 2...... RISK ASSESSMENT: AI IN MEDICAL DIAGNOSTICS MARKET
3.... EXECUTIVE SUMMARY
・ FIGURE 11..... AI IN MEDICAL DIAGNOSTICS MARKET, BY COMPONENT, 2022 VS. 2027 (USD MILLION)
・ FIGURE 12..... AI IN MEDICAL DIAGNOSTICS MARKET, BY APPLICATION, 2022 VS. 2027 (USD MILLION)
・ FIGURE 13. AI IN MEDICAL DIAGNOSTICS MARKET, BY END USER, 2022 VS. 2027 (USD MILLION)
・ FIGURE 14 GEOGRAPHICAL SNAPSHOT OF AI IN MEDICAL DIAGNOSTICS MARKET
4.... PREMIUM INSIGHTS
4.1 AI IN MEDICAL DIAGNOSTICS MARKET OVERVIEW
・ FIGURE 15.... RISING VOLUME OF DIAGNOSTIC IMAGING PROCEDURES AND INFLUX OF BIG DATA TO DRIVE MARKET
4.2 NORTH AMERICA: AI IN MEDICAL DIAGNOSTICS MARKET, BY APPLICATION AND COUNTRY (2021)
・ FIGURE 16 IN VIVO DIAGNOSTICS ACCOUNTED FOR LARGEST SHARE OF NORTH AMERICA IN 2021
4.3 AI IN MEDICAL DIAGNOSTICS MARKET SHARE, BY APPLICATION, 2022 VS. 2027.. 44
・ FIGURE 17. IN VIVO DIAGNOSTICS TO CONTINUE TO DOMINATE MARKET DURING FORECAST PERIOD
4.4 AI IN MEDICAL DIAGNOSTICS MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
・ FIGURE 18 ASIA PACIFIC REGION TO REGISTER HIGHEST GROWTH RATE DURING FORECAST PERIOD
5.... MARKET OVERVIEW
5.1 INTRODUCTION
・ FIGURE 19............... AI IN MEDICAL DIAGNOSTICS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
5.1.1 DRIVERS
5.1.1.1 INFLUX OF BIG DATA
5.1.1.2 GROWING NUMBER OF CROSS-INDUSTRY PARTNERSHIPS & COLLABORATIONS
5.1.1.3 INCREASING DEMAND FOR AI-BASED SOLUTIONS TO REDUCE WORK PRESSURE ON RADIOLOGISTS
5.1.1.4 RISING GOVERNMENT INITIATIVES TO DRIVE AI-BASED TECHNOLOGIES
5.1.1.5 AVAILABILITY OF FUNDING FOR AI-BASED STARTUPS
5.1.2 RESTRAINTS
5.1.2.1 RELUCTANCE AMONG MEDICAL PRACTITIONERS TO ADOPT AI-BASED TECHNOLOGIES
5.1.2.2 INADEQUATE AI WORKFORCE AND AMBIGUOUS REGULATORY GUIDELINES FOR MEDICAL SOFTWARE
5.1.3 OPPORTUNITIES
5.1.3.1 UNTAPPED EMERGING MARKETS
5.1.3.2 GROWING POTENTIAL OF AI IN IMAGING DIAGNOSTICS FOR COVID-19
5.1.3.3 INCREASING FOCUS ON DEVELOPING HUMAN-AWARE AI SYSTEMS
5.1.4 CHALLENGES
5.1.4.1 BUDGETARY CONSTRAINTS
5.1.4.2 UNSTRUCTURED HEALTHCARE DATA
5.1.4.3 DATA PRIVACY CONCERNS
5.1.4.4 LIMITED INTEROPERABILITY FOR AI SOLUTIONS
5.2 VALUE CHAIN ANALYSIS
・ FIGURE 20.......... AI IN MEDICAL DIAGNOSTICS MARKET: VALUE CHAIN
5.3 CASE STUDIES
5.3.1 FOCUS ON IMPROVING WORKFLOW EFFICACY AND REDUCING BURDEN ON RADIOLOGISTS
・ TABLE 3.......... USE CASE 1: REDUCING BURDEN ON RADIOLOGISTS BY DEVELOPING AND TESTING AN AI MODEL TO READ LARGE ULTRASOUND DATA
5.3.2 IMPROVED TRIAGE. 54
・ TABLE 4....... USE CASE 2: PRECISION DRIVEN HEALTH DEVELOPED ML-MODEL TO IMPROVE WORK TRIAGE OF CARDIOLOGISTS (2019)
5.4 ECOSYSTEM COVERAGE
・ FIGURE 21....................... AI IN MEDICAL DIAGNOSTICS: ECOSYSTEM
5.5 TECHNOLOGY ANALYSIS
・ TABLE 5........ TECHNOLOGICAL DEVELOPMENTS BY LEADING VENDORS
5.6 REGULATIONS
5.6.1 HEALTH INSURANCE PORTABILITY AND ACCOUNTABILITY ACT OF 1996 (HIPAA)
5.6.2 HEALTH INFORMATION TECHNOLOGY FOR ECONOMIC AND CLINICAL HEALTH ACT OF 2009 (HITECH)
5.6.3 CONSUMER PRIVACY PROTECTION ACT OF 2017
5.6.4 NATIONAL CYBERSECURITY PROTECTION ADVANCEMENT ACT OF 2015
5.6.5 FUTURE OF LIFE INSTITUTE’S ASILOMAR AI PRINCIPLES
5.6.6 THE EUROPEAN MEDICAL DEVICES REGULATION (EU) 2017/745 AND IN-VITRO DIAGNOSTIC MEDICAL DEVICES REGULATION (EU) 2017/746, IN COMBINATION WITH GENERAL DATA PROTECTION REGULATION 2016/679
5.6.7 CYBERSECURITY LAW OF PEOPLE'S REPUBLIC OF CHINA
5.7 PORTER’S FIVE FORCES ANALYSIS
・ TABLE 6 AI IN MEDICAL DIAGNOSTICS MARKET: PORTER’S FIVE FORCES ANALYSIS
5.8 INDUSTRY TRENDS
5.8.1 ARTIFICIAL INTELLIGENCE IN HEALTHCARE
5.8.1.1 KEY TO AI IN HEALTHCARE: DATA
5.8.1.2 AR AND MR IN HEALTHCARE SETTINGS
5.8.1.3 HEALTHCARE PRIVACY AND SECURITY IN 2022
5.9 PRICING ANALYSIS
5.10 KEY CONFERENCES AND EVENTS (2022−2023)
・ TABLE 7........ AI IN MEDICAL DIAGNOSTICS MARKET: DETAILED LIST OF CONFERENCES AND EVENTS
5.11 KEY STAKEHOLDERS AND BUYING CRITERIA
5.11.1 KEY STAKEHOLDERS IN BUYING PROCESS
・ FIGURE 22... INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR END USERS
・ TABLE 8. INFLUENCE OF STAKEHOLDERS IN BUYING PROCESS FOR END USERS
5.11.2 BUYING CRITERIA.. 61
・ FIGURE 23........................... KEY BUYING CRITERIA FOR END USERS
・ TABLE 9............................... KEY BUYING CRITERIA FOR END USERS
6.... ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET,
BY COMPONENT
6.1 INTRODUCTION
・ TABLE 10....... AI IN MEDICAL DIAGNOSTICS MARKET, BY COMPONENT, 2020–2027 (USD MILLION)
6.2 SOFTWARE
6.2.1 USE OF AI PLATFORMS IN SOFTWARE TO ENHANCE DECISION-MAKING AND SIMPLIFY WORKFLOWS
・ TABLE 11 AI IN MEDICAL DIAGNOSTICS SOFTWARE MARKET, BY REGION, 2020–2027 (USD MILLION)
6.3 SERVICES
6.3.1 RISING NEED FOR DEPLOYMENT & INTEGRATION OF AI SYSTEMS TO SUPPORT MARKET GROWTH
・ TABLE 12 AI IN MEDICAL DIAGNOSTICS SERVICES MARKET, BY REGION, 2020–2027 (USD MILLION)
7.... ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET,
BY APPLICATION
7.1 INTRODUCTION
・ TABLE 13....... AI IN MEDICAL DIAGNOSTICS MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
7.2 IN VIVO DIAGNOSTICS
・ TABLE 14............... AI IN MEDICAL DIAGNOSTICS MARKET FOR IN VIVO DIAGNOSTICS, BY REGION, 2020–2027 (USD MILLION)
7.2.1 IN VIVO DIAGNOSTIC APPLICATIONS MARKET, BY SPECIALTY
・ TABLE 15............... AI IN MEDICAL DIAGNOSTICS MARKET FOR IN VIVO DIAGNOSTICS, BY SPECIALTY, 2020–2027 (USD MILLION). 67
7.2.1.1 RADIOLOGY
7.2.1.1.1 AI-BASED DIAGNOSTIC TOOLS TO REDUCE WORK PRESSURE ON RADIOLOGISTS.. 67
・ TABLE 16..... AI IN MEDICAL DIAGNOSTICS FOR IN VIVO RADIOLOGY, BY REGION, 2020–2027 (USD MILLION)
7.2.1.2 CARDIOLOGY
7.2.1.2.1 RISING COMPLEXITIES ASSOCIATED WITH CVD TO DRIVE MARKET
・ TABLE 17............... AI IN MEDICAL DIAGNOSTICS MARKET FOR IN VIVO CARDIOLOGY, BY REGION, 2020–2027 (USD MILLION)
7.2.1.3 NEUROLOGY
7.2.1.3.1 INCREASING PREVALENCE OF CRITICAL BRAIN DISORDERS TO DRIVE MARKET. 69
・ TABLE 18............... AI IN MEDICAL DIAGNOSTICS MARKET FOR IN VIVO NEUROLOGY, BY REGION, 2020–2027 (USD MILLION)
7.2.1.4 OBSTETRICS/GYNECOLOGY
7.2.1.4.1 RISING USE OF MINIMALLY INVASIVE TECHNIQUES IN GYNECOLOGY PROCEDURES TO DRIVE MARKET
・ TABLE 19............... AI IN MEDICAL DIAGNOSTICS MARKET FOR IN VIVO OBSTETRICS/GYNECOLOGY, BY REGION, 2020–2027 (USD MILLION)
7.2.1.5 OPHTHALMOLOGY
7.2.1.5.1 RISING NEED FOR EARLY DETECTION & PREVENTION OF EYE DISEASES TO DRIVE MARKET
・ TABLE 20............... AI IN MEDICAL DIAGNOSTICS MARKET FOR IN VIVO OPHTHALMOLOGY, BY REGION, 2020–2027 (USD MILLION). 71
7.2.1.6 OTHER SPECIALTIES
・ TABLE 21............... AI IN MEDICAL DIAGNOSTICS MARKET FOR OTHER SPECIALTIES, BY REGION, 2020–2027 (USD MILLION)
7.2.2 IN VIVO DIAGNOSTIC APPLICATIONS MARKET, BY MODALITY
・ TABLE 22............... AI IN MEDICAL DIAGNOSTICS MARKET FOR IN VIVO DIAGNOSTICS, BY MODALITY, 2020–2027 (USD MILLION). 72
7.2.2.1 COMPUTED TOMOGRAPHY
7.2.2.1.1 RISING AVAILABILITY OF CARDIAC CT DEVICES ENABLED WITH AI SOLUTIONS TO DRIVE MARKET
・ TABLE 23......... AI IN MEDICAL DIAGNOSTICS MARKET FOR COMPUTED TOMOGRAPHY, BY REGION, 2020–2027 (USD MILLION). 73
7.2.2.2 X-RAY
7.2.2.2.1 INNOVATIVE AI SOLUTIONS FOR X-RAY IMAGING BY KEY PLAYERS TO DRIVE MARKET
・ TABLE 24 AI IN MEDICAL DIAGNOSTICS MARKET FOR X-RAY, BY REGION, 2020–2027 (USD MILLION)
7.2.2.3 MAGNETIC RESONANCE IMAGING (MRI)
7.2.2.3.1 RISING TECHNOLOGICAL ADVANCEMENTS TO DRIVE ADOPTION OF AI IN MRI
・ TABLE 25.......... AI IN MEDICAL DIAGNOSTICS MARKET FOR MAGNETIC RESONANCE IMAGING, BY REGION, 2020–2027 (USD MILLION)
7.2.2.4 ULTRASOUND
7.2.2.4.1 INCREASING PREVALENCE OF OVARIAN CANCER TO DRIVE MARKET DEMAND
・ TABLE 26. AI IN MEDICAL DIAGNOSTICS MARKET FOR ULTRASOUND, BY REGION, 2020–2027 (USD MILLION)
7.2.2.5 OTHER MODALITIES
・ TABLE 27............... AI IN MEDICAL DIAGNOSTICS MARKET FOR OTHER MODALITIES, BY REGION, 2020–2027 (USD MILLION)
7.3 IN VITRO DIAGNOSTICS
7.3.1 INCREASING ADOPTION OF POINT-OF-CARE TESTING IN EMERGING ECONOMIES TO SUPPORT MARKET GROWTH.. 76
・ TABLE 28. AI IN MEDICAL DIAGNOSTICS FOR IN VITRO DIAGNOSTICS, BY REGION, 2020–2027 (USD MILLION)
8.... ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET, BY END USER
8.1 INTRODUCTION
・ TABLE 29. AI IN MEDICAL DIAGNOSTICS MARKET, BY END USER, 2020–2027 (USD MILLION)
8.2 HOSPITALS
8.2.1 INSTALLATION OF ADVANCED AI DIAGNOSTIC IMAGING SOLUTIONS TO DRIVE MARKET
・ TABLE 30.... AI IN MEDICAL DIAGNOSTICS MARKET FOR HOSPITALS, BY REGION, 2020–2027 (USD MILLION)
8.3 DIAGNOSTIC IMAGING CENTERS
8.3.1 GROWING NUMBER OF PRIVATE IMAGING CENTERS TO DRIVE MARKET
・ TABLE 31....... AI IN MEDICAL DIAGNOSTICS MARKET FOR DIAGNOSTIC IMAGING CENTERS, BY REGION, 2020–2027 (USD MILLION)
8.4 DIAGNOSTIC LABORATORIES
8.4.1 RISING SPECIMEN TEST VOLUME TO DRIVE MARKET
・ TABLE 32....... AI IN MEDICAL DIAGNOSTICS MARKET FOR DIAGNOSTIC LABORATORIES, BY REGION, 2020–2027 (USD MILLION)
8.5 OTHER END USERS
・ TABLE 33......... AI IN MEDICAL DIAGNOSTICS MARKET FOR OTHER END USERS, BY REGION, 2020–2027 (USD MILLION)
9.... ARTIFICIAL INTELLIGENCE IN MEDICAL DIAGNOSTICS MARKET, BY REGION
9.1 INTRODUCTION
・ TABLE 34..... AI IN MEDICAL DIAGNOSTICS MARKET, BY REGION, 2020–2027 (USD MILLION)
9.2 NORTH AMERICA
・ FIGURE 24..... NORTH AMERICA: AI IN MEDICAL DIAGNOSTICS MARKET SNAPSHOT
・ TABLE 35.. NORTH AMERICA: AI IN MEDICAL DIAGNOSTICS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
・ TABLE 36.. NORTH AMERICA: AI IN MEDICAL DIAGNOSTICS MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
・ TABLE 37. NORTH AMERICA: AI IN MEDICAL DIAGNOSTICS MARKET FOR IN VIVO DIAGNOSTICS, BY SPECIALTY, 2020–2027 (USD MILLION)
・ TABLE 38. NORTH AMERICA: AI IN MEDICAL DIAGNOSTICS MARKET FOR IN VIVO DIAGNOSTICS, BY MODALITY, 2020–2027 (USD MILLION)
・ TABLE 39.. NORTH AMERICA: AI IN MEDICAL DIAGNOSTICS MARKET, BY COMPONENT, 2020–2027 (USD MILLION)
・ TABLE 40.. NORTH AMERICA: AI IN MEDICAL DIAGNOSTICS MARKET, BY END USER, 2020–2027 (USD MILLION)
9.2.1 US
9.2.1.1 INCREASING VOLUME OF IMAGING PROCEDURES TO DRIVE MARKET GROWTH
・ TABLE 41.. US: AI IN MEDICAL DIAGNOSTICS MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
・ TABLE 42......... US: AI IN MEDICAL DIAGNOSTICS MARKET FOR IN VIVO DIAGNOSTICS, BY SPECIALTY, 2020–2027 (USD MILLION)
・ TABLE 43......... US: AI IN MEDICAL DIAGNOSTICS MARKET FOR IN VIVO DIAGNOSTICS, BY MODALITY, 2020–2027 (USD MILLION)
・ TABLE 44.. US: AI IN MEDICAL DIAGNOSTICS MARKET, BY COMPONENT, 2020–2027 (USD MILLION)
・ TABLE 45...... US: AI IN MEDICAL DIAGNOSTICS MARKET, BY END USER, 2020–2027 (USD MILLION)
9.2.2 CANADA
9.2.2.1 RESEARCH GRANTS AND IMPROVED ACADEMICS IN RADIOLOGY TO DRIVE MARKET GROWTH
・ TABLE 46............. CANADA: AI IN MEDICAL DIAGNOSTICS MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
・ TABLE 47.. CANADA: AI IN MEDICAL DIAGNOSTICS MARKET FOR IN VIVO DIAGNOSTICS, BY SPECIALTY, 2020–2027 (USD MILLION). 89
・ TABLE 48.. CANADA: AI IN MEDICAL DIAGNOSTICS MARKET FOR IN VIVO DIAGNOSTICS, BY MODALITY, 2020–2027 (USD MILLION). 89
・ TABLE 49............. CANADA: AI IN MEDICAL DIAGNOSTICS MARKET, BY COMPONENT, 2020–2027 (USD MILLION)
・ TABLE 50....... CANADA: AI IN MEDICAL DIAGNOSTICS MARKET, BY END USER, 2020–2027 (USD MILLION)
9.3 EUROPE
・ TABLE 51 EUROPE: AI IN MEDICAL DIAGNOSTICS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
・ TABLE 52............. EUROPE: AI IN MEDICAL DIAGNOSTICS MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
・ TABLE 53.. EUROPE: AI IN MEDICAL DIAGNOSTICS MARKET FOR IN VIVO DIAGNOSTICS, BY SPECIALTY, 2020–2027 (USD MILLION). 91
・ TABLE 54.. EUROPE: AI IN MEDICAL DIAGNOSTICS MARKET FOR IN VIVO DIAGNOSTICS, BY MODALITY, 2020–2027 (USD MILLION)
・ TABLE 55............. EUROPE: AI IN MEDICAL DIAGNOSTICS MARKET, BY COMPONENT, 2020–2027 (USD MILLION)
・ TABLE 56....... EUROPE: AI IN MEDICAL DIAGNOSTICS MARKET, BY END USER, 2020–2027 (USD MILLION)
9.3.1 GERMANY
9.3.1.1 RISING GOVERNMENT SUPPORT TO DRIVE ADOPTION OF AI IN MEDICAL DIAGNOSTICS
・ TABLE 57........... GERMANY: AI IN MEDICAL DIAGNOSTICS MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
・ TABLE 58 GERMANY: AI IN MEDICAL DIAGNOSTICS MARKET FOR IN VIVO DIAGNOSTICS, BY SPECIALTY, 2020–2027 (USD MILLION). 93
・ TABLE 59 GERMANY: AI IN MEDICAL DIAGNOSTICS MARKET FOR IN VIVO DIAGNOSTICS, BY MODALITY, 2020–2027 (USD MILLION). 94
・ TABLE 60........... GERMANY: AI IN MEDICAL DIAGNOSTICS MARKET, BY COMPONENT, 2020–2027 (USD MILLION)
・ TABLE 61..... GERMANY: AI IN MEDICAL DIAGNOSTICS MARKET, BY END USER, 2020–2027 (USD MILLION)
9.3.2 UK
9.3.2.1 INCREASING NUMBER OF RADIOGRAPHY PROCEDURES TO DRIVE MARKET GROWTH.. 95
・ TABLE 62.. UK: AI IN MEDICAL DIAGNOSTICS MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
・ TABLE 63......... UK: AI IN MEDICAL DIAGNOSTICS MARKET FOR IN VIVO DIAGNOSTICS, BY SPECIALTY, 2020–2027 (USD MILLION)
・ TABLE 64......... UK: AI IN MEDICAL DIAGNOSTICS MARKET FOR IN VIVO DIAGNOSTICS, BY MODALITY, 2020–2027 (USD MILLION)
・ TABLE 65.. UK: AI IN MEDICAL DIAGNOSTICS MARKET, BY COMPONENT, 2020–2027 (USD MILLION)
・ TABLE 66...... UK: AI IN MEDICAL DIAGNOSTICS MARKET, BY END USER, 2020–2027 (USD MILLION)
9.3.3 FRANCE
9.3.3.1 AVAILABILITY OF FUNDING FOR COMPANIES TO ENHANCE AI RESEARCH IN MEDICAL IMAGING
・ TABLE 67.............. FRANCE: AI IN MEDICAL DIAGNOSTICS MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
・ TABLE 68... FRANCE: AI IN MEDICAL DIAGNOSTICS MARKET FOR IN VIVO DIAGNOSTICS, BY SPECIALTY, 2020–2027 (USD MILLION). 98
・ TABLE 69... FRANCE: AI IN MEDICAL DIAGNOSTICS MARKET FOR IN VIVO DIAGNOSTICS, BY MODALITY, 2020–2027 (USD MILLION). 98
・ TABLE 70.............. FRANCE: AI IN MEDICAL DIAGNOSTICS MARKET, BY COMPONENT, 2020–2027 (USD MILLION)
・ TABLE 71........ FRANCE: AI IN MEDICAL DIAGNOSTICS MARKET, BY END USER, 2020–2027 (USD MILLION)
9.3.4 ITALY
9.3.4.1 INCREASING VOLUME OF EHRS AND EMRS DUE TO RISING GERIATRIC POPULATION TO DRIVE DEMAND FOR AI SOLUTIONS
・ TABLE 72................. ITALY: AI IN MEDICAL DIAGNOSTICS MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
・ TABLE 73...... ITALY: AI IN MEDICAL DIAGNOSTICS MARKET FOR IN VIVO DIAGNOSTICS, BY SPECIALTY, 2020–2027 (USD MILLION)
・ TABLE 74...... ITALY: AI IN MEDICAL DIAGNOSTICS MARKET FOR IN VIVO DIAGNOSTICS, BY MODALITY, 2020–2027 (USD MILLION)
・ TABLE 75 ITALY: AI IN MEDICAL DIAGNOSTICS MARKET, BY COMPONENT, 2020–2027 (USD MILLION)
・ TABLE 76... ITALY: AI IN MEDICAL DIAGNOSTICS MARKET, BY END USER, 2020–2027 (USD MILLION)
9.3.5 REST OF EUROPE
・ TABLE 77.. REST OF EUROPE: AI IN MEDICAL DIAGNOSTICS MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
・ TABLE 78. REST OF EUROPE: AI IN MEDICAL DIAGNOSTICS MARKET FOR IN VIVO DIAGNOSTICS, BY SPECIALTY, 2020–2027 (USD MILLION)
・ TABLE 79. REST OF EUROPE: AI IN MEDICAL DIAGNOSTICS MARKET FOR IN VIVO DIAGNOSTICS, BY MODALITY, 2020–2027 (USD MILLION)
・ TABLE 80.. REST OF EUROPE: AI IN MEDICAL DIAGNOSTICS MARKET, BY COMPONENT, 2020–2027 (USD MILLION)
・ TABLE 81.. REST OF EUROPE: AI IN MEDICAL DIAGNOSTICS MARKET, BY END USER, 2020–2027 (USD MILLION)
9.4 ASIA PACIFIC
・ FIGURE 25.......... ASIA PACIFIC: AI IN MEDICAL DIAGNOSTICS MARKET SNAPSHOT
・ TABLE 82....... ASIA PACIFIC: AI IN MEDICAL DIAGNOSTICS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
・ TABLE 83....... ASIA PACIFIC: AI IN MEDICAL DIAGNOSTICS MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
・ TABLE 84.. ASIA PACIFIC: AI IN MEDICAL DIAGNOSTICS MARKET FOR IN VIVO DIAGNOSTICS, BY SPECIALTY, 2020–2027 (USD MILLION)
・ TABLE 85.. ASIA PACIFIC: AI IN MEDICAL DIAGNOSTICS MARKET FOR IN VIVO DIAGNOSTICS, BY MODALITY, 2020–2027 (USD MILLION)
・ TABLE 86....... ASIA PACIFIC: AI IN MEDICAL DIAGNOSTICS MARKET, BY COMPONENT, 2020–2027 (USD MILLION)
・ TABLE 87. ASIA PACIFIC: AI IN MEDICAL DIAGNOSTICS MARKET, BY END USER, 2020–2027 (USD MILLION)
9.4.1 CHINA
9.4.1.1 RISING USE OF AI IN CLINICAL DECISION-MAKING TO DRIVE MARKET
・ TABLE 88................ CHINA: AI IN MEDICAL DIAGNOSTICS MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
・ TABLE 89..... CHINA: AI IN MEDICAL DIAGNOSTICS MARKET FOR IN VIVO DIAGNOSTICS, BY SPECIALTY, 2020–2027 (USD MILLION)
・ TABLE 90..... CHINA: AI IN MEDICAL DIAGNOSTICS MARKET FOR IN VIVO DIAGNOSTICS, BY MODALITY, 2020–2027 (USD MILLION)
・ TABLE 91................ CHINA: AI IN MEDICAL DIAGNOSTICS MARKET, BY COMPONENT, 2020–2027 (USD MILLION)
・ TABLE 92. CHINA: AI IN MEDICAL DIAGNOSTICS MARKET, BY END USER, 2020–2027 (USD MILLION)
9.4.2 JAPAN
9.4.2.1 PRESENCE OF STRONG HEALTHCARE INFRASTRUCTURE TO DRIVE UPTAKE OF ADVANCED AI SOLUTIONS
・ TABLE 93................ JAPAN: AI IN MEDICAL DIAGNOSTICS MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
・ TABLE 94..... JAPAN: AI IN MEDICAL DIAGNOSTICS MARKET FOR IN VIVO DIAGNOSTICS, BY SPECIALTY, 2020–2027 (USD MILLION)
・ TABLE 95..... JAPAN: AI IN MEDICAL DIAGNOSTICS MARKET FOR IN VIVO DIAGNOSTICS, BY MODALITY, 2020–2027 (USD MILLION)
・ TABLE 96................ JAPAN: AI IN MEDICAL DIAGNOSTICS MARKET, BY COMPONENT, 2020–2027 (USD MILLION)
・ TABLE 97. JAPAN: AI IN MEDICAL DIAGNOSTICS MARKET, BY END USER, 2020–2027 (USD MILLION)
9.4.3 INDIA
9.4.3.1 FAVORABLE GOVERNMENT INITIATIVES FOR R&D INVESTMENTS TO DRIVE MARKET FOR AI
・ TABLE 98................. INDIA: AI IN MEDICAL DIAGNOSTICS MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
・ TABLE 99...... INDIA: AI IN MEDICAL DIAGNOSTICS MARKET FOR IN VIVO DIAGNOSTICS, BY SPECIALTY, 2020–2027 (USD MILLION)
・ TABLE 100.... INDIA: AI IN MEDICAL DIAGNOSTICS MARKET FOR IN VIVO DIAGNOSTICS, BY MODALITY, 2020–2027 (USD MILLION)
・ TABLE 101............... INDIA: AI IN MEDICAL DIAGNOSTICS MARKET, BY COMPONENT, 2020–2027 (USD MILLION)
・ TABLE 102 INDIA: AI IN MEDICAL DIAGNOSTICS MARKET, BY END USER, 2020–2027 (USD MILLION)
9.4.4 REST OF ASIA PACIFIC
・ TABLE 103.......... REST OF ASIA PACIFIC: AI IN MEDICAL DIAGNOSTICS MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
・ TABLE 104.......... REST OF ASIA PACIFIC: AI IN MEDICAL DIAGNOSTICS MARKET FOR IN VIVO DIAGNOSTICS, BY SPECIALTY, 2020–2027 (USD MILLION)
・ TABLE 105.......... REST OF ASIA PACIFIC: AI IN MEDICAL DIAGNOSTICS MARKET FOR IN VIVO DIAGNOSTICS, BY MODALITY, 2020–2027 (USD MILLION)
・ TABLE 106.......... REST OF ASIA PACIFIC: AI IN MEDICAL DIAGNOSTICS MARKET, BY COMPONENT, 2020–2027 (USD MILLION)
・ TABLE 107.......... REST OF ASIA PACIFIC: AI IN MEDICAL DIAGNOSTICS MARKET, BY END USER, 2020–2027 (USD MILLION). 115
9.5 REST OF THE WORLD
9.5.1 RISING INITIATIVES TO STABILIZE HEALTHCARE SYSTEMS TO DRIVE UPTAKE OF AI-BASED TOOLS
・ TABLE 108 REST OF THE WORLD: AI IN MEDICAL DIAGNOSTICS MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
・ TABLE 109 REST OF THE WORLD: AI IN MEDICAL DIAGNOSTICS MARKET FOR IN VIVO DIAGNOSTICS, BY SPECIALTY, 2020–2027 (USD MILLION)
・ TABLE 110 REST OF THE WORLD: AI IN MEDICAL DIAGNOSTICS MARKET FOR IN VIVO DIAGNOSTICS, BY MODALITY, 2020–2027 (USD MILLION)
・ TABLE 111 REST OF THE WORLD: AI IN MEDICAL DIAGNOSTICS MARKET, BY COMPONENT, 2020–2027 (USD MILLION)
・ TABLE 112 REST OF THE WORLD: AI IN MEDICAL DIAGNOSTICS MARKET, BY END USER, 2020–2027 (USD MILLION)
10.. COMPETITIVE LANDSCAPE
10.1 OVERVIEW
10.2 STRATEGIES ADOPTED BY KEY PLAYERS/RIGHT TO WIN
・ TABLE 113.............. OVERVIEW OF STRATEGIES ADOPTED BY PLAYERS
10.3 REVENUE SHARE ANALYSIS OF TOP MARKET PLAYERS
・ FIGURE 26.............................. REVENUE ANALYSIS OF KEY PLAYERS
10.4 RANKING OF PLAYERS, 2021
・ FIGURE 27...... AI IN MEDICAL DIAGNOSTICS MARKET: RANKING OF KEY COMPANIES (2021)
10.5 COMPETITIVE LEADERSHIP MAPPING
10.5.1 STARS
10.5.2 EMERGING LEADERS.. 122
10.5.3 PERVASIVE PLAYERS.. 122
10.5.4 PARTICIPANTS
・ FIGURE 28.......... AI IN MEDICAL DIAGNOSTICS MARKET: COMPETITIVE LEADERSHIP MAPPING (2021)
10.6 COMPETITIVE LEADERSHIP MAPPING (STARTUPS)
10.6.1 PROGRESSIVE COMPANIES
10.6.2 DYNAMIC COMPANIES.. 124
10.6.3 RESPONSIVE COMPANIES
10.6.4 STARTING BLOCKS.. 124
・ FIGURE 29.......... AI IN MEDICAL DIAGNOSTICS MARKET: COMPETITIVE LEADERSHIP MAPPING FOR STARTUPS (2021)
10.7 COMPETITIVE BENCHMARKING
・ TABLE 114.......... AI IN MEDICAL DIAGNOSTICS MARKET: COMPETITIVE BENCHMARKING OF KEY PLAYERS
・ TABLE 115.......... AI IN MEDICAL DIAGNOSTICS MARKET: APPLICATION FOOTPRINT OF KEY PLAYERS
・ TABLE 116.............. AI IN MEDICAL DIAGNOSTICS MARKET: REGIONAL FOOTPRINT OF KEY PLAYERS
10.8 COMPETITIVE SCENARIO
・ TABLE 117 AI IN MEDICAL DIAGNOSTICS MARKET: PRODUCT LAUNCHES, 2019–2022
・ TABLE 118........................... KEY DEALS, JANUARY 2019–JULY 2022
11.. COMPANY PROFILES
11.1 KEY PLAYERS
(BUSINESS OVERVIEW, PRODUCTS/SERVICES/SOLUTIONS OFFERED, MNM VIEW, KEY STRENGTHS AND RIGHT TO WIN, STRATEGIC CHOICES MADE, WEAKNESSES AND COMPETITIVE THREATS, RECENT DEVELOPMENTS)*
11.1.1 MICROSOFT
・ TABLE 119................................ MICROSOFT: BUSINESS OVERVIEW
・ FIGURE 30...................... MICROSOFT: COMPANY SNAPSHOT (2021)
11.1.2 NVIDIA
・ TABLE 120....................................... NVIDIA: BUSINESS OVERVIEW
・ FIGURE 31....................................... NVIDIA: COMPANY SNAPSHOT
11.1.3 IBM
・ TABLE 121........................................... IBM: BUSINESS OVERVIEW
・ FIGURE 32.......................................... IBM: COMPANY SNAPSHOT
11.1.4 INTEL CORPORATION.. 146
・ TABLE 122......................................... INTEL: BUSINESS OVERVIEW
・ FIGURE 33........................................ INTEL: COMPANY SNAPSHOT
11.1.5 GOOGLE (SUBSIDIARY OF ALPHABET, INC.)
・ TABLE 123..................................... GOOGLE: BUSINESS OVERVIEW
・ FIGURE 34..................................... GOOGLE: COMPANY SNAPSHOT
11.1.6 SIEMENS HEALTHINEERS
・ TABLE 124................ SIEMENS HEALTHINEERS: BUSINESS OVERVIEW
・ FIGURE 35............... SIEMENS HEALTHINEERS: COMPANY SNAPSHOT
11.1.7 GE HEALTHCARE
・ TABLE 125........................... GE HEALTHCARE: BUSINESS OVERVIEW
・ FIGURE 36.......................... GE HEALTHCARE: COMPANY SNAPSHOT
11.1.8 DIGITAL DIAGNOSTICS, INC (FORMERLY KNOWN AS IDX)
・ TABLE 126................... DIGITAL DIAGNOSTICS: BUSINESS OVERVIEW
11.1.9 XILINX
・ TABLE 127........................................ XILINX: BUSINESS OVERVIEW
・ FIGURE 37....................................... XILINX: COMPANY SNAPSHOT
11.1.10 INFORMAI LLC
・ TABLE 128......... INFORMAI: BUSINESS OVERVIEW
*BUSINESS OVERVIEW, PRODUCTS/SERVICES/SOLUTIONS OFFERED, MNM VIEW, KEY STRENGTHS AND RIGHT TO WIN, STRATEGIC CHOICES MADE, WEAKNESSES AND COMPETITIVE THREATS, RECENT DEVELOPMENTS MIGHT NOT BE CAPTURED IN CASE OF UNLISTED COMPANIES.
11.2 OTHER PLAYERS
11.2.1 HEARTFLOW, INC
11.2.2 ENLITIC, INC
11.2.3 DAY ZERO DIAGNOSTICS, INC
11.2.4 AIDENCE
11.2.5 BUTTERFLY NETWORK, INC.
11.2.6 PROGNOS HEALTH
11.2.7 NANOX AI
11.2.8 VIZ.AI, INC
11.2.9 QUIBIM
11.2.10 QURE.AI
11.2.11 THERAPIXEL
11.2.12 AIDOC
11.2.13 KONINKLIJKE PHILIPS N.V.
11.2.14 LUNIT. INC
11.2.15 ECHONOUS INC.
12.. APPENDIX